EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Mohammad Keykhaei, Alexander T Sandhu, Priscilla Y Hsue, Stephen J Greene, Boback Ziaeian, Michelle Kittleson, MaryAnn Villarreal-Gonzalez, Shahin Hallaj, Mattheus Ramsis, Manyoo A Agarwal, Gregg C Fonarow

JACC: Heart Failure · 2026-11 · 14 (11) · 103295

DOI: 10.1016/j.jchf.2026.103295 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JACC: Heart Failure, 2026-11. Verfasst von Mohammad Keykhaei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Adrenergic beta-Antagonists, Mineralocorticoid Receptor Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite robust evidence that quadruple guideline-directed medical therapy (GDMT), comprising angiotensin receptor-neprilysin inhibitors (ARNIs), evidence-based beta-blockers, mineralocorticoid receptor antagonists (MRAs), and sodium-glucose cotransporter 2 (SGLT2) inhibitors, reduces mortality and hospitalizations in heart failure with reduced ejection fraction (HFrEF), implementation in clinical practice remains markedly incomplete. OBJECTIVES: This study aimed to provide updated national estimates of the eligible untreated HFrEF population and to quantify deaths and hospitalizations preventable with optimal implementation of quadruple GDMT in the United States. METHODS: The authors performed a population-level decision analytic modeling study using contemporary U.S. epidemiologic data. National HFrEF prevalence estimates were derived from the American Heart Association Heart Disease and Stroke Statistics 2026 report, and annual HFrEF hospitalization counts were derived from the National Inpatient Sample 2022-2023. Eligible untreated populations were estimated after sequential exclusions and therapy-specific contraindication adjustments using primary treatment rates from Epic Cosmos 2023-2025, with sensitivity analyses using alternative treatment-rate sources. Trial-derived numbers needed to treat and relative risk reductions were applied to estimate deaths preventable over 12 months and annual heart failure (HF) hospitalizations prevented. RESULTS: An estimated 2.76 million U.S. adults with chronic symptomatic HFrEF were eligible for quadruple GDMT, yet only 18.2% received it. Eligible untreated populations included 733,891 for beta-blockers, 1,856,531 for ARNIs, 1,543,967 for MRAs, and 1,717,444 for SGLT2 inhibitors. Class-specific projected deaths preventable over 12 months were 26,210 for beta-blockers, 34,495 for ARNIs, 26,620 for MRAs, and 26,422 for SGLT2 inhibitors; the aggregate estimate across treatment gaps was 113,747 (95% uncertainty interval [UI]: 90,173-149,875). Optimal implementation was also projected to prevent 357,332 HF hospitalizations annually (95% UI: 297,493-425,674). CONCLUSIONS: Incomplete implementation of quadruple GDMT in HFrEF remains a major modifiable opportunity to reduce preventable deaths and HF hospitalizations in the United States.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeAdrenergic beta-AntagonistsMineralocorticoid Receptor AntagonistsAngiotensin Receptor AntagonistsPractice Guidelines as TopicGuideline AdherenceHumansUnited StatesHospitalizationFemaleMaleAgedSodium-Glucose Transporter 2 InhibitorsMiddle Aged

Stichwörter der Autor:innen

guideline-directed medical therapyheart failure with reduced ejection fractionpopulation healthtreatment gaps

Substanzen

Adrenergic beta-AntagonistsMineralocorticoid Receptor AntagonistsAngiotensin Receptor AntagonistsSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Department of Medicine, University of California-San Diego, San Diego, California, USA.
  • Division of Cardiology, Department of Medicine, University of California-San Diego, San Diego, California, USA; Division of Biomedical Informatics, Department of Medicine, University of California-San Diego, San Diego,…
  • Division of Cardiology, Department of Medicine, University of California-San Diego, San Diego, California, USA.

Zitieren

APA

Keykhaei, M., Sandhu, A. T., Hsue, P. Y., Greene, S. J., Ziaeian, B., Kittleson, M., Villarreal-Gonzalez, M., Hallaj, S., Ramsis, M., Agarwal, M. A., & Fonarow, G. C. (2026). National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction. JACC: Heart Failure, 14(11), 103295. https://doi.org/10.1016/j.jchf.2026.103295

Vancouver

Keykhaei M, Sandhu AT, Hsue PY, Greene SJ, Ziaeian B, Kittleson M, et al. National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction. JACC: Heart Failure. 2026;14(11):103295. doi:10.1016/j.jchf.2026.103295

BibTeX
@article{Keykhaei2026,
  author = {Keykhaei, Mohammad and Sandhu, Alexander T and Hsue, Priscilla Y and Greene, Stephen J and Ziaeian, Boback and Kittleson, Michelle and Villarreal-Gonzalez, MaryAnn and Hallaj, Shahin and Ramsis, Mattheus and Agarwal, Manyoo A and Fonarow, Gregg C},
  title = {National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction},
  journal = {JACC: Heart Failure},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {103295},
  doi = {10.1016/j.jchf.2026.103295}
}
Kostenlos starten →